News

During the annual ASCO meeting in June, the US Chinese Anti-Cancer Association (USCACA) held its fourth annual meeting to discuss the emerging role of China in global clinical development of novel anti-cancer drugs.

Tufts CSDD

Moving into electronic methods to facilitate laboratory collections for clinical trials.

The use of flow cytometry can add value in Phase I studies.

Conversion from paper to ePRO for an instrument designed to assess diabetes' impact on quality of life.

Even though thousands of clinical trials are listed on public websites, and sponsors are posting results from more key studies, consumer advocates continue to press for broader public disclosure of information on research involving human subjects.

Practical approaches to new challenges and opportunities in inflammation trials.

S

Regulators must stop approving so many new drugs of very limited therapeutic value, and the European Medicines Agency (EMA) and other regulatory bodies should be fully funded by public money rather than relying on industry-generated user fees, according to an article published by the British Medical Journal.

S

Illuminating the advantages of multiplexing for advanced biomarker testing.